4//SEC Filing
Wallace Eli M. 4
Accession 0001193125-25-231917
CIK 0001869105other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:22 PM ET
Size
5.6 KB
Accession
0001193125-25-231917
Insider Transaction Report
Form 4
Wallace Eli M.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-02+1,614,400→ 1,614,400 totalExercise: $12.44Exp: 2035-10-01→ Common Stock (1,614,400 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 2, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
BridgeBio Oncology Therapeutics, Inc.
CIK 0001869105
Entity typeother
Related Parties
1- filerCIK 0001776352
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:22 PM ET
- Size
- 5.6 KB